Re: Meningococcal vaccine appears safe when administered with other vaccines

[Guest guest]

This is very interesting......I was just reading about the Gardasil vaccine and spinal cord pollutants.  However, after reading this one....I wander if a girl was given this vaccine along with the Gardasil vaccine if they would react to someones body with adverse reactions.  This vaccine is used to protect teens from Meningitis (spinal cord) if it was mixed with Gardasil would both mix together and react to the spinal cord or their other organs.

 

appears safe?

http://www.healio.com/pediatrics/vaccine-preventable-diseases/news/online/%7BB301377F-7533-4A85-9844-E17DA2EF5030%7D/Meningococcal-vaccine-appears-safe-when-administered-with-other-vaccines#perspective

Meningococcal vaccine appears safe when administered with other vaccines

[Guest guest]

Dear Sheri Nakken,

Thank you for posting this article.

My attempted " quick " response (in 3 parts because of the

limited space allowed for comments) was:

Part1

Since: a) the most common serogroup/type for meningococcal

meningitis in children in the USA is " B " and the vaccines

provide no protection against it; only " 150 " clinical

cases are diagnosed in the USA annually in a population of

about 4,200,000 children under 1 year of age; c) the vaccine

is not >95% effective for any of the other " strains " (A, C,

Y, W-135) that are " common " in the USA; d) there is NO proof

that any level of antibodies is EFFECTIVE in preventing those

who are exposed from contracting " meningitis " ; e) the

protection, if any, provided does not last for a " lifetime "

or even 10 years, and, at any given time 10 to 15 % of the

population is " carrying " one or more strains of N. meningitidis

in their nasal mucosa without being infected:

1. The use of this vaccine is NOT, CANNOT be, effective in

preventing those vaccinated with it from getting

" meningococcal m[e]ningitis " , AND

2. The mass use of this vaccine is NOT cost effective.

Part2

Since more than " 50% " of the cases in children under 1 year

of age are the " B " serotype, less than 75 children in a

population of 4.2 million babies POTENTIALLY be protected.

Since the vaccine is not nearly 100% protective for any of

the covered strains and there are other strains, besides " B "

that are known to infect humans, probably < 40 children under

the age of 1 year MIGHT be somewhat protected from having

meningitis.

Presu[m]ing that about " 80% " of children get both doses or

6.72 million doses at a cost of $ 82.12 or 109.66 per dose

(from 3 Aug 2012 CDC price list), an " administration cost

of $50.00 per dose, and 50% at the CDC price, the average

annual cost of adding this vaccine to the US healthcare

system would be about $ 980.38 million dollars.

Presuming that it would stop 40 cases and that " 10% " of

the cases would die, we would still have 110 cases a year

with 11 deaths; the cost to prevent 1 case would be $24.5

million dollars, and the cost to prevent 1 death would be

about $245 million.

Part3

Clearly, the deployment of this vaccine in young children

is not cost effective EXCEPT to Sanofi Past[eu]r (from its

increased Menactra® sales and, based on its like studies,

Novartis from its similar sales of its mystery-composition

MenVeo® vaccine) who would profit from selling more doses.

Finally, the title's claim " appears to be safe " is NO MORE

VALID THAN the " safety " studies used to claim safety for

the individual vaccines that do NOT use a true placebo

(sterile pH-balanced saline with or without glucose at

the actives' level) and NOTHING else for the " control " arm

in ALL safety studies!

Finally, I would like to thank Dr. Block for disclosing

his conflicts of interest and for presenting a relatively

thorough review of the disease realities surrounding

meningococcal disease caused by N. meningitidis in the USA.

Hopefully, some may benefit from the information in this

comment.

Respectfully,

Dr. King

http://www.dr-king.com

*******************************************

*The information provided in this email *

*and any attachment thereto is just that *

* -- information. *

* *

*It is not medical or legal advice and it *

*does not require any specific action or *

*actions. *

* *

*While the information is thought to be *

*accurate, no representation is made as *

*to the accuracy of the information posted*

*other than it is my best understanding of*

*the facts on the date that this email and*

*any non-dated attachments thereto are *

*posted. *

* *

*Everyone should verify the accuracy of *

*the information provided for themselves *

*before acting on it. *

*******************************************

++++++++++++++++++++++++++++++++++++++++++++

Quoting Sheri Nakken :

> appears safe?

>

>

http://www.healio.com/pediatrics/vaccine-preventable-diseases/news/online/%7BB30\

1377F-7533-4A85-9844-E17DA2EF5030%7D/Meningococcal-vaccine-appears-safe-when-adm\

inistered-with-other-vaccines#perspective

>

>

> Meningococcal vaccine appears safe when administered with other vaccines

>

>

>

> ------------------------------------

>

>